At the HSG Healthspan Lab we focus on research to extend the “Healthy Lifespan”

Entrepreneurship typically has been linked to tremendous number of working hours, hugely demanding responsibilities for organizing business structure/environment, decision-making under a high-level of ambiguity and uncertainty that results in a feeling of stress and ultimately leads to problems in sleep and health, as well as a decrease in work performance. The general aim of the current project is to particularly investigate the contribution of sleep status and nutrition on decision-making and entrepreneurial performance and test whether different interventions can improve decisions and health of entrepreneurs.

Non-communicable diseases (NCDs), including common mental disorders, not only impose an enormous health burden on individuals but also lead to substantial economic burdens for healthcare systems. Especially individuals with lower socioeconomic status are affected by NCDs. Digital therapeutics (DTx) have the potential to offer low-cost personalized interventions easing the burden of NCDs and addressing inequalities in health. This project investigates the importance of preventive care and offers a roadmap toward DTx for healthy longevity with a focus on the region of Eastern Switzerland.

Longer life expectancy with a declining younger population leads to an aging society where the older population might consume all resources (Fried, Wong and Dzau, 2022). Longevity with ill health worsens an already dire situation to the point where it is economically unsustainable. On the other hand, healthy longevity can contribute to economic growth through longer occupation (Scott, 2021). Therefore, it is necessary and urgent to promote healthy longevity (HL), that is, the compression of years lived with a disability while also winning healthy years.

Our research team at the Singapore-ETH Centre is dedicated to addressing the rising prevalence of non-communicable diseases (NCDs) and common mental disorders (CMDs) in Southeast Asia, particularly in Singapore. To combat this challenge, we are developing and evaluating a scalable digital health intervention called LvL UP.